// App-Quantinova.ai

719 : Antiphospholipid Syndrome (APS) Patient Plasmas Consistently Activate Complement: A Novel Approach to Detecting a Pathogenic Mechanism for APS

Researchers

Presenter

  • Jacob H. Rand

Principal Investigators

  • Xiao-Xuan Wu

  • Lucia R Wolgast

  • Victor Lei

  • Edward M. Conway

Medical Centers

  • Department of Pathology & Laboratory Medicine, Weill Cornell Medical College, New York, NY

  • Department of Medical Oncology, Montefiore Medical Center, Bronx, NY

  • Centre for Blood Research, University of British Columbia, Vancouver, BC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Antiphospholipid syndrome

  • Venous thrombosis

  • Solid malignancies

  • Stroke

Biomarkers

  • Complement Component 5a

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved